Adults who use proton pump inhibitors are between 16 and 21 percent more likely to experience a heart attack than people who don't use the commonly prescribed antacid drugs, according to a massive new study by Houston Methodist and Stanford University scientists. An examination of 16 million clinical documents representing 2.9 million patients also showed that patients who use a different type of antacid drug called an H2 blocker have no increased heart attack risk. The findings, reported in PLOS ONE, follow a Circulation report in 2013 in which scientists showed how -- at a molecular¹ level -- PPIs might cause long-term cardiovascular disease and increase a patient's heart attack risk.

 

"Our earlier work identified that the PPIs can adversely³ affect the endothelium, the Teflon-like lining⁴ of the blood vessels," said John Cooke, M.D., Ph.D., a senior author of the PLOS ONE report. "That observation led us to hypothesize that anyone taking PPIs may be at greater risk for heart attack. Accordingly, in two large populations of patients, we asked what happened to people that were on PPIs versus⁵ other medications for the stomach."

 

The PLOS ONE study's principal investigator⁶ was Stanford vascular² medicine specialist Nicholas J. Leeper, M.D.

 

In the present study, the researchers found a clear and significant association between exposure to PPIs and the occurrences of heart attack.

 

"By looking at data from people who were given PPI drugs primarily for acid reflux and had no prior history of heart disease, our data-mining pipeline⁷ signals an association with a higher rate of heart attacks," said the PLOS ONE report's lead author, Nigam H. Shah, Nigam H. Shah, M.B.B.S., Ph.D., an assistant professor of biomedical informatics at Stanford, where the work was done. "Our results demonstrate that PPIs appear to be associated with elevated risk of heart attack in the general population, and H2 blockers show no such association."

点击收听单词发音